MUNICH, Germany—Two randomized trials testing different types of interventions for patients with acute intracerebral hemorrhage (ICH), presented here at the European Stroke Organisation Conference ...

Intracerebral hemorrhage (ICH) is a sudden bleed in the brain tissue or ventricles. It carries a high rate of death or functional disability. ICH can be caused by a malformation of blood vessels, ...

The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing. The pharmaceutical industry's efforts to implement ...

The author provides a review of FDA's guidance document, Guidance for Industry: Q11 Development and Manufacture of Drug Substances, and its relation to the International Conference on Harmonization's ...

The International Council for Harmonisation (ICH) has announced the adoption of Annex 2 to the guideline on Good Clinical Practices (GCPs) E6(R3). This annex focuses on the collection of data from a ...

The International Council on Harmonisation (ICH) announced on Friday the adoption of its M14 guideline, which aims to harmonize the planning, design, and reporting of pharmacoepidemiologic studies ...

Intracerebral hemorrhage (ICH) is sudden, catastrophic bleeding that occurs in the brain tissue or ventricles. Symptoms may be sudden and severe, such as headache, loss of consciousness, or vomiting, ...

The final ICH E6 (R3) Good Clinical Practice (GCP) Guidelines were published on 6 th January 2025, updating the framework for clinical trials to reflect modern trial designs, technology, and data ...

The ICH is a unique collaborative initiative involving regulatory authorities and the pharmaceutical industry from around the world. Its mission is to develop harmonized technical guidelines that ...

The ICH E20 guideline, released as a Step-2 draft in June 2025, establishes globally harmonised principles for the planning, conduct, analysis, and interpretation of ...